Technology in Play for Children With Physical Disabilities: the Dice Model of Play
Launched by UNIVERSITY OF MANITOBA · Mar 12, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Technology in Play for Children With Physical Disabilities: the Dice Model of Play," is studying how to help children with physical disabilities play more effectively. The researchers believe that play is crucial for children’s growth and development, but many kids with disabilities face challenges that make it hard for them to play. The goal of this study is to develop a better understanding of what play means for these children and to create a new model that includes different aspects of play. This model will help experts identify and address the barriers that prevent children from enjoying playtime.
To participate in this study, children must be between 3 to 8 years old, have a physical disability, and be able to speak and understand English. The study is looking for children living in Winnipeg. Participants will have the opportunity to build and play with Lego robots over a few weeks, which will help investigators gather information on what helps or hinders their ability to play. At the end of the study, experts will review the new model of play and make improvements based on the feedback from parents and children. This research is important because it aims to ensure that all children, regardless of their abilities, can enjoy their right to play.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Having a disability or typically developed
- • Between 3 to 8 years old
- • Speaking and understanding English or Persian
- • Living in Winnipeg
- Exclusion Criteria:
- • Not receiving play therapy within the last three months
About University Of Manitoba
The University of Manitoba, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive expertise in medical research, public health, and community engagement to conduct rigorous and ethical clinical studies. The institution aims to translate scientific findings into practical applications that enhance patient care and improve health outcomes. Committed to fostering a culture of excellence and integrity, the University of Manitoba prioritizes participant safety and scientific validity in all its clinical research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Winnipeg, Manitoba, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported